BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Episode
34 min
Read time
2 min
Topics
Relationships, Investing, Leadership
AI-Generated Summary
Key Takeaways
- ✓Annual format shift: BioSpain transitions from biennial to annual after registration numbers for the 2026 Bilbao edition tracked on pace with the 2025 Barcelona event, which drew 2,400 attendees from 30+ countries and 1,000+ organizations. Sectors considering Spain as a business destination should register early, as 60% of exhibition spaces are already sold out.
- ✓Partnering system access: BioSpain uses EBD's Partneringone platform, the same system as Bio Europe, allowing attendees to carry forward existing profiles and meeting histories. With 130 dedicated partnering booths and 4,500 meetings arranged at the last edition, registrants who open their profiles in August and actively manage requests can realistically schedule 30–40 one-on-one meetings.
- ✓International entry point for Spanish biotech: Approximately 27% of BioSpain participants come from outside Spain, with 30% of exhibitors being foreign companies. For international firms seeking Spanish partners, investors, or clinical research collaborators, BioSpain offers access to 800–900 Spanish companies in three days — compared to roughly 30 Spanish companies typically present at Bio Europe.
- ✓Talent Day job fair: October 1 functions as a free biotech-specific job fair with no equivalent elsewhere in Spain. HR managers and candidates register separately at biospain.com, upload profiles or job offers, and schedule 20-minute interviews through a dedicated platform. Research centers and universities are targeted directly to funnel PhD and postdoctoral researchers toward the 125+ interview slots available.
- ✓Sponsorship customization: BioSpain offers bronze-to-platinum tiers plus modular sponsorship of specific assets — including the partnering area, mobile app, registration desk, or individual program tracks such as Finance and Investment or Talent Day. Track sponsors receive logo placement plus the ability to co-design a roundtable session, giving targeted visibility to niche audiences within the broader event.
What It Covers
BioSpain 2026, hosted in Bilbao September 29–October 1 at the Bilbao Exhibition Center, marks the event's first annual edition after two decades of biennial scheduling. Acebio's Stuart Medina outlines the partnering system, four program tracks, international delegation opportunities, and a free Talent Day job fair for biotech professionals.
Key Questions Answered
- •Annual format shift: BioSpain transitions from biennial to annual after registration numbers for the 2026 Bilbao edition tracked on pace with the 2025 Barcelona event, which drew 2,400 attendees from 30+ countries and 1,000+ organizations. Sectors considering Spain as a business destination should register early, as 60% of exhibition spaces are already sold out.
- •Partnering system access: BioSpain uses EBD's Partneringone platform, the same system as Bio Europe, allowing attendees to carry forward existing profiles and meeting histories. With 130 dedicated partnering booths and 4,500 meetings arranged at the last edition, registrants who open their profiles in August and actively manage requests can realistically schedule 30–40 one-on-one meetings.
- •International entry point for Spanish biotech: Approximately 27% of BioSpain participants come from outside Spain, with 30% of exhibitors being foreign companies. For international firms seeking Spanish partners, investors, or clinical research collaborators, BioSpain offers access to 800–900 Spanish companies in three days — compared to roughly 30 Spanish companies typically present at Bio Europe.
- •Talent Day job fair: October 1 functions as a free biotech-specific job fair with no equivalent elsewhere in Spain. HR managers and candidates register separately at biospain.com, upload profiles or job offers, and schedule 20-minute interviews through a dedicated platform. Research centers and universities are targeted directly to funnel PhD and postdoctoral researchers toward the 125+ interview slots available.
- •Sponsorship customization: BioSpain offers bronze-to-platinum tiers plus modular sponsorship of specific assets — including the partnering area, mobile app, registration desk, or individual program tracks such as Finance and Investment or Talent Day. Track sponsors receive logo placement plus the ability to co-design a roundtable session, giving targeted visibility to niche audiences within the broader event.
Notable Moment
Medina notes that when Spanish VC funds launched in the early 2000s, most could not deploy more than one million euros — an amount he describes as insufficient to meaningfully advance any biotech project. Today, Spanish funds like Sabi and Inverredi mobilize significantly larger amounts alongside international co-investors.
Episode Transcript
Hello, and welcome to Beyond Biotech, the weekly podcast from LoBioTech. I'm Dylan Kysain, and this is episode 212 for the podcast. Today, I'm thrilled to bring you a special episode highlighting one of Europe's premier biotechnology events, Bio Spain. Joining me is Stuart Medina of Assabio, who will take us inside this landmark gathering. For the first time and in response to strong sector demand and growing interest, Bios Spain moves to an annual format. Hosted this year in vibrant Bilbao in Spain's dynamic Basque Country, the event runs from the September 29 to the October 1 at the Bilbao Exhibition Center. In this episode, we explore the Bayer Spain program, the partnering opportunities on offer, the new talent day, and all the practical and logistical details for attendees. Bios Spain promises unmatched networking and collaboration, and I hope you enjoy my discussion with Stuart Medina from Acebio. Stuart, welcome to Beyond Biotech. Actually, welcome back to Beyond Biotech. Thank you for the invitation. It's a pleasure to talk to you again, once again for an occasion of another edition of BioSpin. You've had a pretty busy year since we last had you on the podcast back in episode one sixty five, almost a year ago now. What have you been doing? Well, obviously, organizing the next edition. We have to start working international activities of the association. It's mostly participating in other international events like Bio Europe, Swiss Swiss biotech days. We usually have a a stand in those events. Also you know, we get international delegations, agreements with other international, clusters, etc. So quite a busy year. We also had the Green Innovation Forum earlier this year in April. Of course, we're here to talk about Bio Spain. This is a fixture in the European biotech calendar since 2003, so nearly twenty five years now. What do you think's helped Bio Spain become just one of the largest partnering events in Europe? Yes. I think it's a good question. I think it's well, there's more than twenty years of history behind this. The Association organized its first Bio Spain in 2003, so more than twenty years of experience. I think also, Acebio has been very good at trying to coalesce, the the all the regional clusters and the sector. And, I think, people understand, even though Spain is a very regionalized country, I think people understand that there's value in having a large national event, and also to internationalize that event, to have it in the English language, so that foreigners can participate and feel comfortable. And that that's another, I think, important, factor. And, I think all in all, also the fact that the industry in Spain has is maturing. We we are seeing a large number of companies in Spain. Some of them have managed to to, do initial public offerings for for a large amount and and and, private placements also for for some significantly large amounts. So there's still ways to go, but …
Get the full transcript (5,334 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
You just read a 3-minute summary of a 31-minute episode.
Get Beyond Biotech summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from Beyond Biotech
Beyond biology: Nanobiotix's physics-first approach to cancer
Aug 21 · 31 min
The AI Breakdown
Fable is Back: Here's What You Should Try First
Jul 1
More from Beyond Biotech
How Cancer Research Horizons is building the future of childhood cancer medicines
Aug 14 · 43 min
Accidental Tech Podcast
688: A Company Man
Apr 21
Books, tools, and gear mentioned in this episode
SignalCast may earn commission on purchases via these links.
Tools
by EBD
“BioSpain uses EBD's Partneringone platform, the same system as Bio Europe, allowing attendees to carry forward existing profiles and meeting histories.”
More from Beyond Biotech
We summarize every new episode. Want them in your inbox?
Beyond biology: Nanobiotix's physics-first approach to cancer
How Cancer Research Horizons is building the future of childhood cancer medicines
Why Western pharma is sleeping on China's circular RNA revolution
Gain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson's
This nonprofit is building the ecosystem to cure epidermolysis bullosa
Similar Episodes
Related episodes from other podcasts
The AI Breakdown
Jul 1
Fable is Back: Here's What You Should Try First
Accidental Tech Podcast
Apr 21
688: A Company Man
The Changelog
Mar 2
Finale & Friends (Friends)
Moonshots with Peter Diamandis
Feb 9
Opus 4.6 Tops Benchmarks, ChatGPT Market Share Decline, and the Privacy Breakdown | EP 228
Moonshots with Peter Diamandis
Feb 5
AGI Debate: Is It Finally Here? | EP #227
Explore Related Topics
This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into Beyond Biotech.
Every Monday, we deliver AI summaries of the latest episodes from Beyond Biotech and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime